BioPharma Dive - Latest News

Galapagos backtracks on planned split

Having now appointed Henry Gosebruch as CEO of the intact company, Galapagos says its priorities are exploring strategic options and “transformative” deals.

May 13, 2025 - 17:28
 0
Galapagos backtracks on planned split

Having now appointed Henry Gosebruch as CEO of the intact company, Galapagos says its priorities are exploring strategic options and “transformative” deals.

Read More

Tags:

Previous Article

Jeep Exec Believes the Electric Recon SUV Will Be Its "New Defender"

Next Article

NATO hosts Colombian Chief of Defence

Related Posts

Sarepta stock plummets as lower sales outlook adds to gloom over FDA’s new biologics hire

Sarepta stock plummets as lower sales outlook adds to g...

May 7, 2025  0

Haya banks $65M to scour the ‘dark genome’ for new drugs

Haya banks $65M to scour the ‘dark genome’ for new drugs

May 8, 2025  0

Prasad’s FDA appointment pressures cell and gene therapy stocks

Prasad’s FDA appointment pressures cell and gene therap...

May 6, 2025  0